A new study led by researchers in the United States has found that obesity might contribute to faster progression of ...
Weight-loss drugs have “little or no effect” on reducing the risk of cancers related to obesity, according to a new study.
About one in eight adults say they are taking a GLP-1 receptor agonist as a treatment for obesity, diabetes or another ...
While type 1 and type 2 diabetes typically occupy distinct places in healthcare, research is showing an increase of patients ...
Now, emerging evidence has also linked ultraprocessed foods with poor gut health, according to Kevin Whelan, a professor of ...
Popular weight-loss drugs “probably have little or no effect” on a person’s risk of developing one of the 13 obesity-related ...
Increases in levels of blood biomarkers of Alzheimer disease seen over time for all participants, with faster rates of increase for individuals with obesity.
The coexistence of type 2 diabetes and obesity represents a major global health challenge that significantly increases cardiovascular and metabolic risk.
A wave of demand for weight-loss medication is sweeping South Korea, a country that remains one of the OECD’s leanest, as ...
Walk into a typical supermarket in the United States, and much of what you see -- breakfast cereals, frozen meals, processed meats, sodas -- is considered ultraprocessed food.
The researchers assessed the association between Alzheimer’s biomarkers and body mass index (BMI), according to a press ...
Hepatitis doesn’t always announce itself. While hepatitis A often comes on abruptly, as with a bad stomach bug, most cases of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results